Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Orange, California

Phase 1 cancer trials in Orange, CA

36 Phase 1 cancer studies are recruiting participants at sites in Orange as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Orange at a glance

  • 36 studies are recruiting at a site in Orange.
  • By phase: Early Phase 1 (2), Phase 1 (17), Phase 1/2 (17).
  • By sponsor: industry (23), university, hospital or other (8), government (5).
  • By research area: Lung Cancer (9), Lymphoma (9), Breast Cancer (6), Pancreatic Cancer (6), Melanoma (3), Prostate Cancer (3).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Orange

Basic details from each study's public record (the 30 most recently updated of 36). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    University of California Irvine
    Registry record
    NCT06324357 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    UC Irvine Health-Chao Family Comprehensive Cancer Center
    Registry record
    NCT07488676 · updated
  3. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    University of California Irvine Medical Center
    Registry record
    NCT05983432 · updated
  4. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    UC Irvine Health - Chao Family Comprehensive Cancer Center
    Registry record
    NCT05208762 · updated
  5. Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center University of California, Irvine
    Registry record
    NCT07064018 · updated
  6. A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Day One Biopharmaceuticals, Inc.
    Study site
    UC Irvine Health-Chao Family Comprehensive Cancer Center
    Registry record
    NCT05377996 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Lung cancer studies recruiting in Orange

  1. A Study of VET3-TGI in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    KaliVir Immunotherapeutics
    Study site
    UC Irvine Health
    Registry record
    NCT06444815 · updated
  2. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    University of California Irvine
    Registry record
    NCT04886804 · updated
  3. A 2-part Phase 1/2 Open-label Trial on ODM-212

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Orion Corporation, Orion Pharma
    Study site
    UC Irvine Health
    Registry record
    NCT07563738 · updated
  4. A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    University of California - Irvine
    Registry record
    NCT07140016 · updated
  5. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UC IRVINE Health
    Registry record
    NCT06128551 · updated
  6. A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    University Of California Irvine Medical Center /ID# 270507
    Registry record
    NCT06858813 · updated
  7. First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Plexium, Inc.
    Registry record
    NCT07284186 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Orange

  1. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    UCI Health Chao Family Comprehensive Cancer Center
    Registry record
    NCT05997615 · updated
  2. A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of California-Irvine Medical Center ( Site 0016)
    Registry record
    NCT06863272 · updated
  3. A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Shenzhen Ionova Life Sciences Co., Ltd.
    Study site
    UC Irvine Medical Center
    Registry record
    NCT06609005 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Melanoma studies recruiting in Orange

  1. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    University of California Irvine
    Registry record
    NCT05655312 · updated
  2. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Children's Hospital of Orange County
    Registry record
    NCT04851119 · updated
  3. Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Irvine
    Study site
    Chao Family Comprehensive Cancer Center, University of California, Irvine
    Registry record
    NCT07628634 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Orange, CA on ClinicalTrials.gov.

Lymphoma studies recruiting in Orange

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Children's Hospital of Orange County
    Registry record
    NCT04726241 · updated
  2. TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

    • Phase 1/2
    • Up to age 1
    • All sexes
    Sponsor
    Tanja Andrea Gruber
    Study site
    Children's Hospital of Orange County
    Registry record
    NCT05848687 · updated
  3. A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Nuvalent Inc.
    Study site
    University of California Irvine Medical Center
    Registry record
    NCT05384626 · updated
  4. Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT06860594 · updated
  5. Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT07332507 · updated
  6. Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT07069699 · updated
  7. CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

    • Phase 1/2
    • From 12 months, up to 21 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Children's Hospital of Orange County
    Registry record
    NCT04870944 · updated
  8. Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

    • Early Phase 1
    • Ages 1 to 31
    • All sexes
    Sponsor
    New York Medical College
    Study site
    Children's Hospital Orange County
    Registry record
    NCT03719105 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Orange, CA on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Orange

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05372614 · updated
  2. Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UC Irvine Health/Chao Family Comprehensive Cancer Center
    Registry record
    NCT05687123 · updated
  3. A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    University of California Irvine Medical Center
    Registry record
    NCT05365581 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Orange, CA on ClinicalTrials.gov.

Ask about studies near Orange

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call